The aim of this study was to determine how luteal cells of the hormone-primed (luteinized) ovary process low density lipoproteins (LDL). Ovary uptake of perfused '"I-LDL was assessed by tissue levels of radioactivity; the distribution of LDL protein in cells was assessed on autoradiograms of the fixed tissue; and the level of stimulation of steroidogenesis, as well as degradation of LDL protein, was assessed on effluent perfusion samples. Human LDL ligand used in these studies was rigorously defined biochemically and physiologically. Homologous (rat) LDL was used as a special ligand control. Other tissue controls included the use of perfused or in vivo-infused luteinized ovaries from animals pretreated to reduce circulating lipoprotein levels, perfused ovaries from a second hormone-primed model, perfused liver from estrogen-treated rats, and isolated and cultured cells from the same ovarian tissues used in the perfusion experiments.
Introduction
Most steroid hormone-producing tissues (e.g., ovary and adrenal) obtain the major supply of cholesterol needed for steroidogenesis from circulating cholesterol-rich lipoproteins (1, 2) . In the rat, it is believed that the predominant exogenous lipoprotein source of cholesterol is the high density lipoprotein (HDL) particle (3), although it is clear that both HDL and the less available (2, 3) low density lipoproteins (LDL) can, in fact, be bound by steroidproducing cells and stimulate steroidogenesis under similar in vivo and in vitro circumstances (2) . To what extent the rat's steroid hormone-producing tissues discriminate between HDL and LDL during binding or in the cholesterol-processing phase is not yet clear. Indeed, it is not yet certain whether or not the two lipoproteins are recognized by the same receptor sites on the cells.
In a recent study we began reexamining the issue of how steroid hormone-producing cells ofthe rat utilize HDL: we used 251I-labeled human HDL (hHDL) as the ligand, and followed its time-related uptake during perfusion of hormone-primed luteinized ovaries of immature rats (4) . Our results showed that the luteinized ovary responded to HDL perfusion with a dramatic increase in progesterone production, but, at the same time, the intact HDL particle was not internalized by the hormone-producing cells. Instead, we found in electron microscopic autoradiographs prepared of ovaries perfused for up to 2 h with labeled HDL, that -90% ofthe exposed grains (representing sites ofHDL protein) remained associated with the plasma membrane of the luteal cells. Moreover, the few exposed grains that were present within the confines ofthe luteal cell cytoplasm were not specifically associated with cell organelles (vesicles, vacuoles, or lysosomes) generally considered to be part ofthe endocytic-degradative pathway (5) . It was of interest that the same results obtained whether human HDL3 (lacking apolipoprotein [apo]' E) or rat HDL (known to contain -12% apo E [3] ) had been used as the perfused ligand. This finding with apo E-containing HDL brought up the possibility that rat luteal cells "in vivo" may not have an active B/E receptor pathway for processing lipoproteins, and, as such, further complicated the issue of how such cells discriminated between HDL and the apo B-containing LDL.
In the current study, we examined this issue still further by directly using LDL as the lipoprotein of choice. Experiments similar to those previously described for HDL (4) were carried out except the perfused (or intravenously infused) ligand was changed to 251I-hLDL. Steroidogenesis, kinetics of LDL uptake and degradation by the intact ovary, and the distribution of the labeled LDL on luteal cells, as determined by electron microscope autoradiograms, were evaluated as before.
Various other rat tissues were used as special controls. For one, perfusion experiments with '25I-LDL were carried out on luteinized ovaries from rats whose circulating lipoprotein levels had been reduced to <10% of normal values by pretreatment of the animals with 4-aminopyrazolo [3,4-d] pyrimidine (6) . In addition, LDL uptake by the pregnant mare serum gonadotropin (PMSG)-treated (granulosa cell-differentiated) ovary (7) was examined as a second steroidogenic tissue. LDL uptake by the perfused livers ofestrogen-primed rats (8, 9) was used as a positive control for tissue uptake of LDL by the classical endocytic-degradative pathway (5) . The uptake of homologous (rat) LDL was used as a control for the heterologous (human) ligand used in the majority of the present experiments. And finally, isolated cultured luteal cells and granulosa cells (from the same ovarian tissues used in the perfusion experiments) and fibroblasts in culture were incubated with the labeled LDL in vitro as a means of estimating ligand quality in established systems (10) .
Methods
Perfusion experiments TISSUE MODELS. Luteinized ovary. Immature female Sprague-Dawley rats (Simonsen Laboratories, Fremont, CA) were hormone-primed with PMSG and human chorionic gonadotropins (hCG) as previously described (1 1, 12) . The luteinized ovaries from these animals provided the major in situ organ perfusion model for the present study: ovarian tissue was used for biochemical and structural studies, and collagenase-isolated luteal cells from these ovaries were maintained in culture for incubation with ligand as described below.
Luteinized ovary from animals treated with 4-aminopyrazolo [3,4- (8, 9) . Livers from these animals were used for morphologic observation only and were intended to provide a nonsteroidal tissue control for the perfused ovarian tissues described above.
PERFUSION PROTOCOL. The methodology used in this study was similar to that described previously for HDL (4) , except that in this study flow to all abdominal organs except the genital tract was excluded, and that perfusion effluent represented collection solely from the ovary, uterus, and some musculature surrounding these tissues. The perfusion sequence for all experiments (except those for kinetic data) was as follows: 2-min washout with oxygenated Medium 199 or McCoy's 5a media (pH 7.4, 33-35°C), followed by 50 min (occasionally 120 min) of nonrecirculating (flow-through) ligand perfusion at 1-2 m/min and a 2-min wash with media (2 ml/min). At this point the ovaries were either excised and counted for radioactivity, or the tissues were perfusion-fixed with glutaraldehyde before processing for preparation ofautoradiographs (ARGs). No differences were seen in cell morphology or in the distribution of '25I-LDL after the use of Medium 199 or McCoy's 5a media.
Hepatic perfusion was carried out for morphologic purposes only. Two types of procedures were used. In some cases rat livers were perfused by precisely the same LDL ligand-media preparation and the same conditions used to perfuse the luteinized ovaries. In other cases, rat livers were perfused with ligand in Krebs-Ringer buffer supplemented with freshly prepared washed human red blood cells (25% hematocrit) and 4% albumin, as done for standard liver perfusion studies (13) . No differences were detected in the distribution of ligand by the two perfusion methods.
The basic experimental protocol for this study was as follows: (a) determination of the kinetics of LDL uptake in luteinized ovaries using as an endpoint the accumulation of total ovary radioactivity after perfusion with '25I-hLDL (3-5 ACi/ml) for varying periods of time (15-180 min) and with different concentrations of LDL (25-1,000 Mg ofprotein/ ml); (b) assessment of competition of 10-fold excess unlabeled hLDL or unlabeled hHDL3 for the tissue-associated labeled ligands; (c) determination ofthe progesterone response ofluteinized ovaries to the perfusion of varying concentrations (10, 50, 100, 500, 1,000 Mg of protein/ml) of unlabeled hLDL for I h; (d) determination of the LDL degradation in perfusate effluent; and (e) the localization of either '251I-h or rat (r)LDL (45 MCi/ml, 50-500 ug ofprotein/ml) on cells ofeach ofthe tissue models discussed above, using ARG at both the light (LM) and electron microscopic (EM) level.
In vivo experiments
To test the efficacy of the perfusion models of the luteinized ovary in identifying the localization of exogenously supplied 251I-LDL, two experiments were carried out in which the ligand was slowly infused into 4-APP-treated, luteinized rats and permitted to circulate with the blood for 1 h before perfusion fixation of the ovaries. At the start of these experiments a cannula was inserted into the jugular vein of lightly anesthetized animals (Surital, sodium thiamylal) and 125I-LDL (1.5 mCi/ml; 3.1 mg protein/ml) was infused at a rate of 0.05 ml for 15 min, then at 0.02 ml for the remaining 45 min of the experiment. The animals remained lightly anesthetized throughout the procedure. At the end of I h the abdomen ofthe animals was opened and the ovaries were prepared for in situ perfusion of fixative as before. Medium 199 was perfused for 2 min (2.5 ml/min) to flush the ovaries of blood and immediately thereafter the ovaries were perfused with glutaraldehyde fixative (4). Subsequently, the radioactivity of the intact fixed ovaries was assessed (using a LKB gamma counter, LKB Instruments Inc., Gaithersburg, MD), and the tissue was processed for LM and EM ARGs. Only a minimum number of these experiments were carried out because it was necessary to use high levels of radioactivity (2.5 mCi) for the purpose of EM ARGs, and it was difficult to protect the perfusionist from exposure during surgical preparation of the radioactive animals.
Isolated cell studies
Isolated rat luteal cells (12) and rat granulosa cells (14) were plated for 2-48 h in petri dishes with McCoy's 5a (15) medium (and in some cases with Dulbecco's modified Eagle's medium:Ham's F12 [1:1]) containing 10% lipoprotein-deficient fetal bovine serum (LPDS) before labeled (±10-fold excess unlabeled) ligand was added for 1-2-h incubation periods. After incubation with the radioactive ligand, the cells were rapidly washed four times with cold (4°C) fresh media and fixed in situ with 1% glutaraldehyde in 0.1 M cacodylate buffer. Subsequently, the cells were pelleted and prepared for EM ARGs as described previously (4) .
On occasion, gold-labeled LDL was prepared (16, 17) and used for incubation of cells as described above. Although no differences in ligand uptake by cells were noted for the differently labeled LDL in vitro, it should be mentioned that gold-labeled LDL cannot be used for in situ perfusion of ovaries insofar as the gold ligand does not pass through the basement membrane that surrounds each luteal cell, unless that region is damaged by excessively high perfusion flow rates (E. Reaven, personal observation).
Miscellaneous techniques
PREPARATION OF LIPOPROTEINS. Human (h) lipoproteins were isolated from fresh plasma of healthy male donors (containing 8 U/ml of kallikrein inactivator and 1 mM diisopropyl fluorophosphate [18] ) by preparative ultracentrifugation (19) in a 60 Ti rotor (Beckman Instruments, Inc., Palo Alto, CA) at 58,000 rpm. hLDL and hHDL3 fractions were isolated between densities of 1.020 and 1.050 g/ml (20) and 1.125 and 1.210 g/ml (21), respectively. Each fraction was recentrifuged for 18 h at the appropriate density to minimize plasma protein contamination. rLDL was isolated between densities of 1.020 and 1.050 and used without any further purification (22) . Isolated lipoprotein fractions were dialyzed against 0.15 M NaCI, 3 mM EDTA, pH 7.4, at 40C for 24 h.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was carried out as described previously (4) . As shown in Fig. 1 , hLDL contained apo B, and hHDL contained apo Al as the major apoproteins.
Cholesterol in the serum, LDL, or in HDL3 fractions was determined enzymatically by the reagents (kit) supplied by Reagents Applications, Inc., San Diego, CA. The protein content oflipoproteins was determined by a modification of the procedure of Lowry et al. (23) by Goldstein and Brown (5, 10) . Human fibroblasts were maintained for 48-72 h in 60-mm petri dishes (I or 2 X 10 cells per dish) containing Dulbecco's modified Eagle's medium, 10% LPDS, 100 U/ml penicillin G, and 100 gg/ml streptomycin. Subsequently, the cells were incubated for 3 hat 37°C with indicated concentrations of '25I-hLDL in the presence and absence of unlabeled LDL. Uptake and degradation assays were performed as described by Goldstein and Brown (10) . All degradation data refer to moniodide, trichloroacetic acid-soluable radioactivity. LDL uptake by fibroblasts was a saturable process: the equilibrium dissociation constant (Kd) was 8.6 stg of LDL protein/ml; degradation of LDL was reduced in the presence of 10-fold excess unlabeled lipoprotein. These data showed that the iodo-labeled LDL used in the present experiments was actively metabolized by fibroblasts, and suggested that in vivo and in vitro differences noted in the present studies were not due to an alteration in the lipoprotein particle itself.
(b) Rat granulosa cells were maintained as described above for 48 h in 35-mm dishes (-2 X 10' cells per dish) with 10% lipoprotein-deficient fetal calf serum; Subsequently the cells were incubated for 3 h at 37°C
with 5, 10, 20, 40, 60, 80, and 100 ,ug protein/ml concentrations of 125I-LDL (500 cpm/ng protein). Uptake and degradation assays were performed as described by Goldstein and Brown (10) .
(c) For studies involving the in vivo uptake and degradation of 125[-LDL, two separate sets of superovulated rats were injected either with saline or hCG (25 IU) s.c. 1 h after saline or hCG treatment, ovaries of these animals were perfused with 1251-LDL (1 MCi; 100 gg protein/ml)
for I h at a flow rate of 1.1 ml/min. 12 fractions (5 ml) each were collected and assayed for LDL degradation as described by Goldstein and Brown (10) . CHARACTERIZATION OF '251I-hHDL BOUND TO OVARY TIS-SUE MEMBRANES. SDS-PAGE was used to determine whether radioactivity was still associated with apo B after perfusion and binding of LDL to luteinized ovaries. A luteinized ovary plasma membrane-enriched fraction was isolated as described previously (4) . 50 g of the membrane fraction from perfused ovaries or 10 Mg of purified 1251I-LDL was loaded on SDS-PAGE and subjected to electrophoresis. Protein bands were identified with molecular weight standards and purified apo B and radioactive proteins in the samples were identified by radioautography.
MEASURMENT OF PROGESTINS. Progesterone (27) and its metabolite, 20 a-hydroxypregn-4ene-3-one (28), was quantitated by radioimmunoassay using specific antiserum.
MORPHOLOGIC TECHNIQUES. All morphologic procedures used in this study have been described in a previous report from this laboratory (4) . For data analysis, 10 nucleated parenchymal cells from each of three blocks per tissue sample were photographed at a low magnification (X 4,000) so as to include an image of the entire cell. For heavily labeled cells from the luteinized ovary, selection was totally random (i.e., the first 10 nucleated cells to appear on the screen were chosen): for cells from other tissues or from cultures, some preselection was necessary to insure the analysis of cells with sufficient numbers of exposed grains. The number of exposed grains counted per cell also varied with the sample and with the length of exposure of the autoradiograph: in general, profiles of luteal cells contained from 15 to 40 grains. Thus, because ovaries from five luteinized animals perfused with hLDL were used in this study, -3,500 exposed grains were counted for this aspect of the study alone.
Materials
Carrier-free '25I-iodine (-17 Ci/mg), [1,2- (Fig. 2 B) , after which the curve flattens. Whether true saturation occurs between the second and third hour of perfusion, or whether tissue function begins to decline after this prolonged procedure, is not clear.
Competition for the uptake of labeled LDL occurs when luteinized ovaries are perfused with 10-fold unlabeled hLDL or hHDL3. In Table I , ovaries were perfused for 30 min with '25I hLDL (100 Mg of protein/ml, 5 MCi/ml) with (or without) unlabeled ( 1,000 MAg ofprotein/ml) hLDL or hHDL3. As indicated, the addition ofeither excess LDL or HDL3 reduces tissue uptake of LDL by -90%.
ARGs of SDS-PAGE of plasma membrane-enriched fractions obtained from luteinized ovaries perfused for 1 h with 125jI LDL (500 Mg of LDL protein/ml, 5 MCi/ml) indicated that the radioactivity was exclusively associated with apo B: no other protein bands were detected (data not shown).
That perfused LDL are capable ofinducing and maintaining steroid production is seen by data such as displayed in Fig. 3 . Here, the luteinized ovaries of animals were perfused on the same day with saturating levels of hLDL (1,000 ,g of protein/ ml) for 1 h; l-ml effluent samples obtained from the vena cava were assayed for progesterone and 20 a-hydroxypregn-4ene-3-one levels by radioimmunoassay. Fig. 3 with LDL results in a dramatic increase in secretion of progesterone and its metabolite, 20 a-hydroxypregn-4ene-3-one (progestins), as compared with ovaries perfused for a similar period without LDL (control). On the other hand, less than saturating levels of LDL protein (i.e., 100-500 ,g of protein/ml) are associated with a submaximal hormone response, and small levels of LDL protein (10-50 ,ug of protein/ml) do not induce a progestin response (Table II) . (Fig. 6 ) indicates that the exposed grains are associated with both upright and inverted microvilli and in every respect resemble the distribution of labeled HDL3 in similarly perfused luteinized ovaries (4) .
Localization of labeled LDL in perfused 4-APP-treated luteinized ovary, in vivo infused 4-APP luteinized ovary, PMSGtreated (granulosa cell-differentiated) ovary, and liver. EM ARGs of '251I-LDL perfused ovaries from 4-APP-treated rats show identical distribution of label to that seen in non-4-APP-treated luteinized ovaries. Moreover, EM ARGs of 125I-LDL in vivo infused ovaries from 4-APP-treated rats show identical distribution of label to that seen in in situ perfused non4-APP-treated luteinized ovaries: i.e., -90% of the label remains with the plasma membrane of luteal cells (Fig. 7) . The only notable difference in the in vivo labeled ovaries is the rather large amount of labeling of nonluteal cells (thecal, connective tissue, and endothelial cells) of the tissue (data not shown).
Similarly, EM ARGs of 125I-LDL perfused ovaries of the granulosa cell model show that only the surface ofthe granulosa cells are labeled (29) . Only rarely are exposed grains found within the cytoplasm of the cells.
In contrast, EM ARGs of '25I-LDL perfused estrogen-treated liver shows that most of the exposed grains are present within cells with a large majority of the internalized grains closely associated with lysosomal-like vacuoles (Fig. 8) Am.
.A* .:
AW 41]., w Figure 6 . Higher-magnification view of association of exposed grains with luteal cell microvilli (125-hLDL, 500 ,g/ml, 45 ACi/ml). Grains are seen on both upright (asterisks) and inverted microvilli (arrows). This distribution of LDL resembles that seen in ovaries perfused under identical conditions with hHDL (see Reaven et al. [4] ). X 80,000.
Degradation of I251-LDL by the perfused luteinized ovary and by granulosa cells in culture. In view of the unexpected morphologic differences noted in LDL uptake by steroid-producing cells in situ and in vitro, it seemed prudent to examine the issue further-this time using the degradation of LDL as an indicator of lipoprotein uptake, internalization and utilization. Perfusion effluent was collected from luteinized ovaries of "control" rats (injected with saline) and hormonally "stimulated" rats (injected with hCG 1 h prior to perfusion) and assayed for levels of LDL degradation. No evidence of degradation of the protein moiety of LDL was observed when the ovaries were perfused with '25I-LDL for up to 1 h, regardless of whether the rats had been stimulated with hCG or not: i.e., trichloroacetic acid-soluble, noniodide 125I accounted for 0.0 17% and 0.008% of the total radioactivity of the samples from saline and hCGtreated rats, respectively. On the other hand, the hCG injection resulted in a rapid and significant increase in plasma progestin levels: mean (±SE) levels of progesterone and 20 a-hydroxy preg-4-ene-3-one for control rats were 440 (±77) and 132 (±9) ng/ ml, respectively, where the same plasma hormone levels in stimulated rats were 2,592 (±293) and 985 (±50) ng/ml, respectively. Thus, total plasma progestin levels for control rats equaled 571 (±84) ng/ml, whereas total plasma protestin levels for hCGstimulated rats equaled 3,577 (±288) ng/ml-a sixfold increase.
In contrast to the lack of LDL degradation observed in the perfused ovaries, results in Fig. 11 show the uptake of 251I-LDL to be a saturable and specific process in granulosa cells in vitro. The equilibrium constant (Kd) calculated for this process was 22 ,ug of LDL protein/ml. Fig. 11 ,.z r.ñ~~~~~~~~~7 1~~~~~~~~~~~~~~~~~~~~~~~~1 Figure 8 . Autoradiograph of bile canalicular surface of hepatocytes from estrogen-treated liver perfused for I h with hLDL (100 tsg of protein/ml; 45 ,uCi/ml). Exposure 6 wk. In contrast to the situation in the ovaries (Figs. 5-7) , most of the exposed grains are found within the cytoplasm of hepatocytes associated with lysosomal-like vacuoles (arrows). X 50,000.
ulosa cells) in situ do not utilize LDL cholesterol by the classical endocytic-lysosomal pathway (5). Instead, the large majority of the labeled protein moiety of LDL (whether from homologous or heterologous sources) remains constantly associated with the plasma membrane surface of the cells, even though steroidogenesis is dramatically increased. The general distribution ofthe labeled LDL protein on the luteal cell surface and particular localization of the LDL protein to specialized sites of inverted microvilli strongly reminds one of the recently described association of HDL protein with the same cells (4 (4) . In all, these experiments show that under the condition of this study, LDL "binds" to the same sites on the cell surface where HDL "binds" and suggests that LDL cholesterol (like HDL cholesterol) must be obtained by cells by a mechanism that does not require internalization of the intact lipoprotein particle (2, 4) . To what extent such a process could correspond to the LDL receptorindependent pathway previously described in rats by Koelz These cells internalize varying amounts of label. In A, lysosomes are labeled (arrows). X 30,000. In B, funneling of the LDL into coated pits (arrows) on the outstretched extremity of one cell is clearly shown using gold-labeled ligand. X 70,000.
evidence for a common HDL and LDL receptor site on cells has been obtained in cell systems such as adipocytes (34) , that previous reports using steroid tissues (35, 36) provide evidence for separate receptor sites for the uptake of LDL and HDL. Obviously, further work involving specific chemically modified lipoprotein particles will be necessary before the issue raised in the present study regarding a common HDL and LDL binding site in the rat ovary can be resolved.
To a large extent, the results of this study depend on the legitimacy of both the tissue model and the labeled ligand used in the study, and we have attempted to take every precaution in this regard. First, the ovary was examined as both a granulosa cell and luteal cell-differentiated model: furthermore, luteinized ovaries from control and/or lipoprotein-deprived (4-APP) animals were examined after the administration of ligand by two different routes-by perfusion and/or by intravenous injection. In all situations, the results were the same and showed that in situ the protein portion ofthe exogenously provided LDL binds to, and remains associated with, the complex microvillar surface of the steroidogenic cells during the course of the study.
In an effort to control ligand quality, each preparation of hLDL was rigorously characterized. The binding and degradation of LDL by fibroblasts was identical to that previously described (10) and the morphologic internalization and association with coated pits, endosomes, and lysosomes (32) In addition, the morphologic uptake of the labeled hLDL by estrogentreated liver (with induced LDL receptor sites [8, 9] ) or by granulosa cells in culture (37) was found to be identical to that described in other laboratories (1, 2, 5) . An important control involved the use of homologous LDL. Insofar as hLDL had previously been shown to have low affinity for rat tissues (34, 38) , it was necessary to compare the effect ofthe human-derived lipoprotein with that obtained directly from rats. Owing to the scarcity of rat LDL and the nonrecirculating nature of our perfusion studies, we could not conduct the entire study with the homologous ligand, but when radiolabeled rLDL was, in fact, used, its morphologic distribution was identical to that seen with hLDL. Of course, the final and most important control was the fact that perfusion with hLDL in luteinized ovaries or incubation with hLDL in luteal cells and granulosa cells in culture was directly associated with a strong steroidogenic response. Thus, we are confident that the ligand used in these studies was fully characteristic of LDL, and, at the same time, was a suitable biologic source of cholesterol for the steroidogenic tissues. As such, we are now proposing that rat luteal and granulosa cells in situ utilize LDL cholesterol for steroidogenesis, but appear to do so without internalizing the intact LDL particle. In this respect, the ovarian steroidogenic cells seem to process LDL in situ just as they do HDL (4).
In formulating this view we have been mindful of the fact that a small percentage (~-10%) of the exposed grains labeling the luteal cells in situ appear to lie within the cytoplasm of the cells. If these grains do, in fact, represent internalized intact LDL though the isolated luteal cell sheds most of its complex microvillar surface after collagenase treatment, a large number of these vesiculated structures remain associated with the luteal cell surface during incubation and continue to "bind" the labeled ligand (asterisks). x 70,000.
(perhaps reflecting a high-affinity receptor-mediated process), one wonders whether they can deliver enough cholesterol to the luteal cells to account for the amount of progestins synthesized. Calculations2 based on the information given in Table II show this to be an unlikely possibility: that is, the amount ofcholesterol which could be released from these "internalized" particles accounts for no more than 2% of that necessary to sustain the observed steroid hormone production. Several other observations confirm this impression. For one, although 10% of the luteal cell-associated grains appear over the cytoplasm of the cells in in situ experiments, they do not show specific association with cytoplasmic organelles (endosomes, lysosomes, Golgi bodies), which are normally associated with the LDL endocytic process. Second, if a high-affinity LDL receptor pathway were to exist, then even low concentrations of perfused LDL should elicit a progesterone response: our results show that perfusion concentrations of 10-50 ,g of LDL protein/ml did not result in measurable progestin release, and that 100-500 ug of LDL protein/ 2. This calculation is based on a perfusion delivery of 100 gg of LDL protein/ml for 60 min. Given an average uptake of 3.0 gg protein/ovary and assuming that all bound radioactivity is, in fact, associated with the luteal cells of the tissue and that LDL protein to cholesterol mass ratio is 1: 1, then the luteal cells of the ovary receive 3.0 jug of cholesterol from the 1-h perfusion. If 10% ofthis cholesterol is internalized, and assuming 100% conversion, -300 ng of cholesterol is available to account for the 600 ng of progestins produced (Table II) . However, in other luteal cell systems studied the steroid-producing cells are able to convert only 0.1-4.0% ofthe available qholesterol to steroid hormones (39, 40) (4) ] and the sucrose tag remains trapped in these sites. Given the differences noted between the in vitro and in vivo LDL uptake behavior of steroidogenic cells in the present study, it is conceivable that such an event could occur-and it could explain the conflicting points of view between the sucrose-tagged LDL studies and our own.
Additional, nonmorphologic evidence in support of the notion that rat luteal cells in situ can utilize LDL-cholesterol without internalizing the intact particle was provided by the fact that no perceptible LDL protein degradation occurred during the 1- , it is not known whether this tissue is capable of endocytosis of any ligand. Questions relating to the more general nature of these findings in other rat tissues, and in other species, will be explored in subsequent studies.
